BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6878514)

  • 1. The relationship between prolactin levels and clinical ratings in manic patients treated with oral and intravenous test doses of haloperidol.
    Cookson JC; Moult PJ; Wiles D; Besser GM
    Psychol Med; 1983 May; 13(2):279-85. PubMed ID: 6878514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin response to neuroleptic challenge.
    Shur E; Checkley S
    Br J Psychiatry; 1982 Apr; 140():431-2. PubMed ID: 7093623
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma prolactin and growth hormone levels in manic patients treated with pimozide.
    Cookson JC; Silverstone T; Rees L
    Br J Psychiatry; 1982 Mar; 140():274-9. PubMed ID: 7093595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration.
    Möller HJ; Kissling W; Lang C; Doerr P; Pirke KM; von Zerssen D
    Am J Psychiatry; 1982 Dec; 139(12):1571-5. PubMed ID: 7149056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin response to single and multiple doses of haloperidol in schizophrenic patients.
    Ravichandran GK; Lu RB; Shvartsburd A; Misra CH; Ho BT; Kahn M; Smith RC
    Psychiatry Res; 1984 Jan; 11(1):61-9. PubMed ID: 6584932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men.
    Rubin RT; Hays SE
    Psychopharmacology (Berl); 1979 Mar; 61(1):17-24. PubMed ID: 108715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.
    Copolov DL; Keks NA; Kulkarni J; Singh BS; McKenzie D; McGorry P; Hill C
    Psychoneuroendocrinology; 1990; 15(3):225-31. PubMed ID: 2255750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose and blood levels of haloperidol in treatment of mania.
    Rifkin A; Karajgi B; Doddi S; Cooper T
    Psychopharmacol Bull; 1990; 26(1):144-6. PubMed ID: 2371369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lithium on prolactin responses to thyrotropin releasing hormone in patients with manic state.
    Tanimoto K; Maeda K; Yamaguchi N; Chihara K; Fujita T
    Psychopharmacology (Berl); 1981; 72(2):129-33. PubMed ID: 6782601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
    Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
    Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis.
    Swigar ME; Jatlow PI; Goicoechea N; Opsahl C; Bowers MB
    Am J Psychiatry; 1984 Oct; 141(10):1281-3. PubMed ID: 6486269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cortisol levels in mania: associated clinical ratings and changes during treatment with haloperidol.
    Cookson JC; Silverstone T; Williams S; Besser GM
    Br J Psychiatry; 1985 May; 146():498-502. PubMed ID: 4016458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimanic effect of clonazepam.
    Chouinard G; Young SN; Annable L
    Biol Psychiatry; 1983 Apr; 18(4):451-66. PubMed ID: 6407539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol stimulation of prolactin secretion: how many blood samples are needed to define the hormone response?
    Rubin RT; Forster B
    Commun Psychopharmacol; 1980; 4(1):41-7. PubMed ID: 7398241
    [No Abstract]   [Full Text] [Related]  

  • 16. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
    Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
    Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
    Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
    Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients.
    Aschauer HN; Schönbeck G; Langer G; Koinig G; Resch F; Hatzinger R; Chaudry HR; Sieghart W
    Pharmacopsychiatry; 1988 Sep; 21(5):246-51. PubMed ID: 3227055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
    Meltzer HY; Fang VS; Tricou BJ; Robertson A; Piyaka SK
    Am J Psychiatry; 1982 Jun; 139(6):763-8. PubMed ID: 7081489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of methadone on the behavioral and neuroendocrine responses of manic patients.
    Judd LL; Parker DC; Janowsky DS; Segal DS; Risch SC; Huey LY
    Psychiatry Res; 1982 Oct; 7(2):163-70. PubMed ID: 6959168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.